http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021205379-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_76ba102ea9c02b6633d64bf09c5b89a4 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-747 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-747 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
filingDate | 2019-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2237fde4842775d75a7087442f351796 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e7a3c640f0459c7d537d3645bb30c5a |
publicationDate | 2021-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-2021205379-A1 |
titleOfInvention | Mechanistic bacterial efector to prevent apoptosis of human beta cells |
abstract | A composition is provided herein, including microvesicles (MVs) isolated from a naturally occurring probiotic Lactobacillus sp. wherein the MVs are packaged in a capsule, emulsion, or tablet such that the packaged MVs are protected in a gastrointestinal tract for transport to an intestine of a subject. In another embodiment, a method for treating Type-1 diabetes including orally administering to a diabetic or pre-diabetic subject, or a subject at risk for becoming pre-diabetic or diabetic, a composition comprising an effective amount of microvesicles isolated from a naturally occurring probiotic strain comprising a Lactobacillus sp.i. In still a further embodiment, of improving immune function in a subject, comprising administering to the subject, the composition comprising an effective amount of microvesicles isolated from a naturally occurring probiotic Lactobacillus sp. |
priorityDate | 2018-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 132.